News

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...